Patient Guide: Expanded Access Protocol of ELI-002-102 in Subjects With KRAS/NRAS Mutated Pancreatic Ductal Adenocarcinoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 0 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07083479
Status: AVAILABLE
Condition: Pancreatic Ductal Adenocarcinoma, KRAS G12D, KRAS G12V, KRAS G12S, KRAS G12A, KRAS G12C, KRAS G12R, KRAS G13D, NRAS G12D, NRAS G12V, NRAS G12S, NRAS G12A, NRAS G12C, NRAS G12R, NRAS G13D
Phase: Not Specified

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Expanded Access Protocol of ELI-002-102 in Subjects With KRAS/NRAS Mutated Pancreatic Ductal Adenocarcinoma - Join Clinical Trial NCTNCT07083479

How to Join This Clinical Trial - NCTNCT07083479

Learn how to participate in this Not Specified trial studying an investigational therapy for Pancreatic Ductal Adenocarcinoma, KRAS G12D, KRAS G12V, KRAS G12S, KRAS G12A, KRAS G12C, KRAS G12R, KRAS G13D, NRAS G12D, NRAS G12V, NRAS G12S, NRAS G12A, NRAS G12C, NRAS G12R, NRAS G13D. Current status: AVAILABLE.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Pancreatic Ductal Adenocarcinoma, KRAS G12D, KRAS G12V, KRAS G12S, KRAS G12A, KRAS G12C, KRAS G12R, KRAS G13D, NRAS G12D, NRAS G12V, NRAS G12S, NRAS G12A, NRAS G12C, NRAS G12R, NRAS G13D. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Pancreatic Ductal Adenocarcinoma, KRAS G12D, KRAS G12V, KRAS G12S, KRAS G12A, KRAS G12C, KRAS G12R, KRAS G13D, NRAS G12D, NRAS G12V, NRAS G12S, NRAS G12A, NRAS G12C, NRAS G12R, NRAS G13D
Treatment Being Tested
Investigational treatment
Study Phase
Not Specified - Research study
Enrollment Status
AVAILABLE
Study Identifier
NCTNCT07083479 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at multiple locations. Find a study site near you:

How to Enroll in This Study

To learn more about participating in this Not Specified clinical trial for Pancreatic Ductal Adenocarcinoma, KRAS G12D, KRAS G12V, KRAS G12S, KRAS G12A, KRAS G12C, KRAS G12R, KRAS G13D, NRAS G12D, NRAS G12V, NRAS G12S, NRAS G12A, NRAS G12C, NRAS G12R, NRAS G13D:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships